» Authors » Tamara Perez-Jeldres

Tamara Perez-Jeldres

Explore the profile of Tamara Perez-Jeldres including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 275
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Ramirez-Suastegui C, Harris R, Castaneda-Castro F, Ascui G, Perez-Jeldres T, et al.
Nat Immunol . 2024 Jun; 25(7):1231-1244. PMID: 38898157
To understand the role of T cells in the pathogenesis of ulcerative colitis (UC), we analyzed colonic T cells isolated from patients with UC and controls. Here we identified colonic...
2.
Perez-Jeldres T, Magne F, Ascui G, Alvares D, Orellana M, Alvarez-Lobos M, et al.
Front Med (Lausanne) . 2023 Nov; 10:1258395. PMID: 37964883
Background And Aims: Latin American populations remain underrepresented in genetic studies of inflammatory bowel diseases (IBDs). Most genetic association studies of IBD rely on Caucasian, African, and Asian individuals. These...
3.
Perez-Jeldres T, Bustamante M, Segovia-Melero R, Aguilar N, Magne F, Ascui G, et al.
Int J Mol Sci . 2023 Oct; 24(19). PMID: 37834314
Lactose intolerance (LI) and vitamin D deficiency (VDD) have been linked to inflammatory bowel disease (IBD). We conducted an observational study in 192 Chilean IBD patients to investigate the prevalence...
4.
Cazanga V, Palma C, Casanova T, Rojas D, Barrera K, Valenzuela C, et al.
Antibiotics (Basel) . 2023 Apr; 12(4). PMID: 37107001
Background: Experimental reports have demonstrated that florfenicol (FFC) exerts potent anti-inflammatory effects, improving survival in a murine endotoxemia model. Considering the anti-inflammatory and immunomodulatory properties of pentoxifylline (PTX) as an...
5.
Dicker M, Li Y, Giles D, Verstichel G, Castelan V, Ascui-Gac G, et al.
Front Immunol . 2022 Nov; 13:1034648. PMID: 36389671
Colitis is characterized by an exacerbated intestinal immune response, but the genetic and other mechanisms regulating immune activation remain incompletely understood. In order to identify new pathways leading to colitis,...
6.
Perez-Jeldres T, Pizarro B, Ascui G, Orellana M, Cerda-Villablanca M, Alvares D, et al.
Medicine (Baltimore) . 2022 Sep; 101(36):e30216. PMID: 36086782
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn disease (CD), has emerged as a global disease with an increasing incidence in developing and newly industrialized regions such as...
7.
Perez-Jeldres T, Alvarez-Lobos M, Rivera-Nieves J
Drugs . 2021 Jul; 81(12):1451. PMID: 34328627
No abstract available.
8.
Perez-Jeldres T, Alvarez-Lobos M, Rivera-Nieves J
Drugs . 2021 May; 81(9):985-1002. PMID: 33983615
Sphingosine-1-phosphate (S1P) is a bioactive lipid metabolite that exerts its actions by engaging 5 G-protein-coupled receptors (S1PR1-S1PR5). S1P receptors are involved in several cellular and physiological events, including lymphocyte/hematopoietic cell...
9.
Riffelmacher T, Giles D, Zahner S, Dicker M, Andreyev A, McArdle S, et al.
Mucosal Immunol . 2021 Feb; 14(3):679-690. PMID: 33568785
Inflammatory bowel disease is characterized by an exacerbated intestinal immune response, but the critical mechanisms regulating immune activation remain incompletely understood. We previously reported that the TNF-superfamily molecule TNFSF14 (LIGHT)...
10.
Tyler C, Guzman M, Lundborg L, Yeasmin S, Perez-Jeldres T, Yarur A, et al.
J Crohns Colitis . 2020 Apr; 14(10):1364-1377. PMID: 32239151
Background And Aims: Intestinal biopsy sampling during IBD trials represents a valuable adjunct strategy for understanding drug responses at the tissue level. Given the length and distinctive embryonic origins of...